JP2025501452A5 - - Google Patents
Info
- Publication number
- JP2025501452A5 JP2025501452A5 JP2024533052A JP2024533052A JP2025501452A5 JP 2025501452 A5 JP2025501452 A5 JP 2025501452A5 JP 2024533052 A JP2024533052 A JP 2024533052A JP 2024533052 A JP2024533052 A JP 2024533052A JP 2025501452 A5 JP2025501452 A5 JP 2025501452A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence described
- binding substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288162P | 2021-12-10 | 2021-12-10 | |
| US63/288,162 | 2021-12-10 | ||
| PCT/US2022/081253 WO2023108114A2 (en) | 2021-12-10 | 2022-12-09 | Human mesothelin binders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501452A JP2025501452A (ja) | 2025-01-22 |
| JP2025501452A5 true JP2025501452A5 (enExample) | 2025-12-15 |
Family
ID=86731328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533052A Pending JP2025501452A (ja) | 2021-12-10 | 2022-12-09 | ヒトメソテリン結合物質 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4444757A4 (enExample) |
| JP (1) | JP2025501452A (enExample) |
| KR (1) | KR20240114766A (enExample) |
| CN (1) | CN118660911A (enExample) |
| AU (1) | AU2022407541A1 (enExample) |
| CA (1) | CA3239553A1 (enExample) |
| MX (1) | MX2024007054A (enExample) |
| WO (1) | WO2023108114A2 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2195017T1 (sl) * | 2007-10-01 | 2015-01-30 | Bristol-Myers Squibb Company | Človeška protitelesa, ki vežejo mezotelin in njihova uporaba |
| PE20170917A1 (es) * | 2010-12-20 | 2017-07-12 | Genentech Inc | Anticuerpos anti-mesotelina e inmunoconjugados |
| WO2014004549A2 (en) * | 2012-06-27 | 2014-01-03 | Amgen Inc. | Anti-mesothelin binding proteins |
| CA3063362A1 (en) * | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Msln targeting trispecific proteins and methods of use |
| GB201811450D0 (en) * | 2018-07-12 | 2018-08-29 | F Star Delta Ltd | Mesothelin and CD137 binding molecules |
| CN114008071B (zh) * | 2018-12-27 | 2025-01-21 | 吉加根公司 | 抗ctla-4结合蛋白及其使用方法 |
| WO2020205849A1 (en) * | 2019-04-01 | 2020-10-08 | Lakepharma, Inc. | Btla-binding (cd272) antibodies for modulating immune response and treating disease |
-
2022
- 2022-12-09 JP JP2024533052A patent/JP2025501452A/ja active Pending
- 2022-12-09 WO PCT/US2022/081253 patent/WO2023108114A2/en not_active Ceased
- 2022-12-09 KR KR1020247022588A patent/KR20240114766A/ko active Pending
- 2022-12-09 MX MX2024007054A patent/MX2024007054A/es unknown
- 2022-12-09 EP EP22905403.6A patent/EP4444757A4/en active Pending
- 2022-12-09 CA CA3239553A patent/CA3239553A1/en active Pending
- 2022-12-09 AU AU2022407541A patent/AU2022407541A1/en active Pending
- 2022-12-09 CN CN202280090785.9A patent/CN118660911A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2023503180A (ja) | 抗ヒトクローディン１８．２抗体及びその適用 | |
| JP2023511774A5 (enExample) | ||
| JP2021516973A5 (enExample) | ||
| JP2021533726A5 (enExample) | ||
| US20200347130A1 (en) | CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof | |
| RU2012112340A (ru) | Гуманизированные моноклональные антитела к сеа с созревшей аффинностью | |
| JP2006506955A5 (enExample) | ||
| JP2021525546A5 (enExample) | ||
| JP2010504755A5 (enExample) | ||
| KR920702425A (ko) | Cdr 이식된 항-cea 항체 및 그의 제조 | |
| JP2013524773A5 (enExample) | ||
| JP2021524478A5 (enExample) | ||
| RU2008126242A (ru) | Антитела против глобуломера а бета, их антигенсвязывающие части, соответствующие гибридомы, нуклеиновые кислоты, векторы, клетки-хозяева, способы получения указанных антител, композиции, содержащие указанные антитела, применения указанных антител и способы использования указанных антител | |
| RU2011103125A (ru) | КОМБИНАЦИЯ АНТАГОНИСТА c-Met И АМИНОГЕТЕРОАРИЛА ДЛЯ ЛЕЧЕНИЯ РАКА | |
| JP2022532173A5 (enExample) | ||
| JP2023548529A5 (enExample) | ||
| JP2019205480A5 (enExample) | ||
| JP2023549537A5 (enExample) | ||
| JP2024541680A5 (enExample) | ||
| JP2024016024A5 (enExample) | ||
| CN114591434A (zh) | 抗Siglec15抗体及其制备方法和用途 | |
| CN112480259A (zh) | 抗tnfr2抗体及其用途 | |
| JP2020531003A5 (enExample) | ||
| JP2022517216A5 (enExample) |